Systemic Effects of Intravitreal Anti-VEGF Therapy: A Review of Safety across Organ Systems
Abstract Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapies have transformed the management of retinal diseases such as diabetic macular edema and neovascular age-related macular degeneration. However, concerns about their systemic absorption and potential adverse effects on...
Saved in:
| Main Authors: | Mousumi Banerjee, Sikshya Moharana, Srikanta Kumar Padhy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-06-01
|
| Series: | Ophthalmology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40123-025-01157-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management and safety of same day bilateral intravitreal anti-VEGF injections in a treat-and-extend regimen
by: Christina Plasencia, et al.
Published: (2025-08-01) -
Ocular pharmacokinetics of intravitreal conbercept in a rabbit model following retinal scatter laser photocoagulation
by: Lanlan Chen, et al.
Published: (2025-04-01) -
Effect of Intravitreal Anti-Endothelial Growth Factor Agents on Renal Function in Patients With Diabetes Mellitus
by: Marta Rivero, et al.
Published: (2024-05-01) -
Vascular Endothelial Growth Factors: Pharmacological aspects and applications in ophthalmic practices
by: Ashok K Dubey, et al.
Published: (2013-10-01) -
Contributing factors to short-term intraocular pressure elevation following intravitreal anti-VEGF injections
by: Yanchen Liu, et al.
Published: (2025-05-01)